ALL vs VXRT · P/E 4.9, $56.89B cap vs rev $28.7M
The Allstate Corporation (ALL) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the ALL and VXRT stock pages for the full models.
Not investment advice.